Hisun Biomaterials
Produces polylactic acid (PLA) resins for 3D printing filaments and other applications, enabling biodegradable and sustainable additive manufacturing materials.
- CEO / Founder
- Chen Zhiming
- Team Size
- 201-500
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- IPO
- Key Investors
- Zhejiang Haituan Co., Ltd., Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Taizhou Jiaojiang District State-owned Assets Management Co., Public Investors
Technology & Products
Key Products
REVODE701 (PLA modified resin); REVODE161 (PLA resin for 3D printing filament); REVODE110 (high optical purity PLA)
Technological Advantage
Proprietary PLA production process from renewable resources (cassava, maize) with high biodegradability and food contact safety; vertically integrated from raw materials to resin.
Differentiation
Value Proposition
Provides high-performance PLA resins that reduce environmental impact by offering biodegradable alternatives to traditional plastics, with applications in 3D printing, packaging, and textiles.
How They Differentiate
Focus on PLA resin production with proprietary lactide technology, offering localized supply in China vs. international competitors; products specifically tailored for 3D printing filaments.
Market & Competition
Target Customers
3D printing filament manufacturers, packaging companies, textile producers, and industrial manufacturers seeking biodegradable materials
Industry Verticals
3D Printing; Packaging; Textiles; Catering Supplies
Competitors
NatureWorks LLC; TotalEnergies Corbion PLA S.A.; Nanjing Tianan Biological Material Co., Ltd.
Growth & Milestones
Growth Metrics
Expanded capacity with a 150,000-ton annual PLA project in Taizhou in 2021, achieving domestic PLA scale industrialization from scratch over nearly 20 years.
Major Milestones
Listed on Shanghai Stock Exchange (stock code 688203); Recognized as top 8 leading bio-PLA companies to watch in 2025